We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » White House Says H.R. 3’s Flaws Outweigh Its Benefits
White House Says H.R. 3’s Flaws Outweigh Its Benefits
The White House Council of Economic Advisers yesterday joined in the debate over the impact of H.R. 3, a drug pricing bill currently awaiting a vote on the House floor.